Prevention of vincristine-induced peripheral neuropathy by genetic deletion of SARM1 in mice

Attenuated traumatic axonal injury and improved functional outcome after traumatic brain injury in mice lackingSarm1

(2016) Nils Henninger et al.   BRAIN

Axon Self-Destruction: New Links among SARM1, MAPKs, and NAD+ Metabolism

(2016) Josiah Gerdts et al.   NEURON

Pathological Axonal Death through a MAPK Cascade that Triggers a Local Energy Deficit

(2015) Jing Yang et al.   CELL

Association of an Inherited Genetic Variant With Vincristine-Related Peripheral Neuropathy in Children With Acute Lymphoblastic Leukemia

(2015) Barthelemy Diouf et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Patterns and severity of vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia

(2015) Ellen M. Lavoie Smith et al.   JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM

Exogenous induction of HO-1 alleviates vincristine-induced neuropathic pain by reducing spinal glial activation in mice

(2015) Yan Shen et al.   NEUROBIOLOGY OF DISEASE

Chemotherapy-induced peripheral neuropathy: What do we know about mechanisms?

(2015) V.A. Carozzi et al.   NEUROSCIENCE LETTERS

Chemotherapy-induced peripheral neuropathies: an integrative review of the literature

(2015) Talita Cassanta Costa et al.   Revista da Escola de Enfermagem da USP

SARM1 activation triggers axon degeneration locally via NAD+ destruction

(2015) J. Gerdts et al.   SCIENCE

Absence of SARM1 Rescues Development and Survival of NMNAT2-Deficient Axons

(2015) Jonathan Gilley et al.   Cell Reports

P7C3 Neuroprotective Chemicals Function by Activating the Rate-Limiting Enzyme in NAD Salvage

(2014) Gelin Wang et al.   CELL

Chemotherapy-induced peripheral neuropathy and its impact on health-related quality of life among ovarian cancer survivors: Results from the population-based PROFILES registry

(2014) Nicole P.M. Ezendam et al.   GYNECOLOGIC ONCOLOGY

Chemotherapy-induced peripheral neuropathies in hematological malignancies

(2014) Joost Louis Marie Jongen et al.   JOURNAL OF NEURO-ONCOLOGY

Electrophysiological, behavioral and histological characterization of paclitaxel, cisplatin, vincristine and bortezomib-induced neuropathy in C57Bl/6 mice

(2014) Wolfgang Boehmerle et al.   Scientific Reports

P7C3 Neuroprotective Chemicals Block Axonal Degeneration and Preserve Function after Traumatic Brain Injury

(2014) Terry C. Yin et al.   Cell Reports

Chemotherapy-induced peripheral neuropathy in adults: a comprehensive update of the literature

(2014) Andreas Argyriou et al.   Cancer Management and Research

Chemotherapy-Related Neuropathic Symptoms and Functional Impairment in Adult Survivors of Extracranial Solid Tumors of Childhood: Results From the St. Jude Lifetime Cohort Study

(2013) Kirsten K. Ness et al.   ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION

Sarm1, a neuronal inflammatory regulator, controls social interaction, associative memory and cognitive flexibility in mice

(2013) Chia-Wen Lin et al.   BRAIN BEHAVIOR AND IMMUNITY

Structural and Molecular Alterations of Primary Afferent Fibres in the Spinal Dorsal Horn in Vincristine-Induced Neuropathy in Rat

(2013) Karine Thibault et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

Sarm1-Mediated Axon Degeneration Requires Both SAM and TIR Interactions

(2013) J. Gerdts et al.   JOURNAL OF NEUROSCIENCE

Quality of life following completion of treatment for adult acute lymphoblastic leukemia with a pediatric-based protocol

(2013) Elena Liew et al.   LEUKEMIA RESEARCH

Effects of eribulin, vincristine, paclitaxel and ixabepilone on fast axonal transport and kinesin-1 driven microtubule gliding: Implications for chemotherapy-induced peripheral neuropathy

(2013) Nichole E. LaPointe et al.   NEUROTOXICOLOGY

Subcellular Localization Determines the Stability and Axon Protective Capacity of Axon Survival Factor Nmnat2

(2013) Stefan Milde et al.   PLOS BIOLOGY

Persistent chemoneuropathy in patients receiving the plant alkaloids paclitaxel and vincristine

(2012) Jessica A. Boyette-Davis et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Axon degeneration: Molecular mechanisms of a self-destruction pathway

(2012) Jack T. Wang et al.   JOURNAL OF CELL BIOLOGY

Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of amyotrophic lateral sclerosis

(2012) R. Tesla et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of Parkinson disease

(2012) H. De Jesus-Cortes et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

dSarm/Sarm1 Is Required for Activation of an Injury-Induced Axon Death Pathway

(2012) J. M. Osterloh et al.   SCIENCE

Sarm1, a negative regulator of innate immunity, interacts with syndecan-2 and regulates neuronal morphology

(2011) Chiung-Ya Chen et al.   JOURNAL OF CELL BIOLOGY

Evaluation of pre-existing neuropathy and bortezomib retreatment as risk factors to develop severe neuropathy in a mouse model

(2011) Jordi Bruna et al.   JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM

Endogenous Nmnat2 Is an Essential Survival Factor for Maintenance of Healthy Axons

(2010) Jonathan Gilley et al.   PLOS BIOLOGY

Suppressive Effect of Imipramine on Vincristine-Induced Mechanical Allodynia in Mice

(2009) Fumihiro Saika et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

The Immune Adaptor Molecule SARM Modulates Tumor Necrosis Factor Alpha Production and Microglia Activation in the Brainstem and Restricts West Nile Virus Pathogenesis

(2009) K. J. Szretter et al.   JOURNAL OF VIROLOGY